ICON plc (ICLR)

153.41
NASDAQ : Health Technology
Prev Close 156.31
Day Low/High 153.06 / 157.58
52 Wk Low/High 118.10 / 165.13
Avg Volume 230.20K
Exchange NASDAQ
Shares Outstanding 54.08M
Market Cap 8.45B
EPS 6.00
P/E Ratio 26.54
Div & Yield N.A. (N.A)
3 Health Care Stocks Pushing Sector Growth

3 Health Care Stocks Pushing Sector Growth

TheStreet highlights 3 stocks pushing the health care sector higher today.

ICON Reports Fourth Quarter And Full Year 2014 Results And Issues 2015 Earnings Guidance

ICON Reports Fourth Quarter And Full Year 2014 Results And Issues 2015 Earnings Guidance

ICON plc (NASDAQ:ICLR), a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the fourth quarter...

ICON To Acquire MediMedia Pharma Solutions

ICON To Acquire MediMedia Pharma Solutions

ICON plc (NASDAQ:ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced it has agreed, subject to certain customary closing...

11 Best Mid-Cap Health Care Stocks Worth Targeting for 2015

11 Best Mid-Cap Health Care Stocks Worth Targeting for 2015

Which mid-cap health care companies should you target for the best returns? Click through to see which stocks are top-rated.

ICON Selected By The FDA To Develop New Patient-Reported Outcome Measure For Hospital-Acquired Bacterial Pneumonia Trials

ICON Selected By The FDA To Develop New Patient-Reported Outcome Measure For Hospital-Acquired Bacterial Pneumonia Trials

ICON plc, (NASDAQ: ICLR) a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has been awarded a project by the US ...

ICON Reports Third Quarter 2014 And Increases Earnings Guidance

ICON Reports Third Quarter 2014 And Increases Earnings Guidance

ICON plc , (NASDAQ: ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the third quarter...

ICON Plc Announces Completion Of $40 Million Share Buyback And A Further Share Buyback Program For Up To $100 Million

ICON Plc Announces Completion Of $40 Million Share Buyback And A Further Share Buyback Program For Up To $100 Million

ICON plc, (Nasdaq: ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, announced today that it has completed a $40 million buyback of...

Medidata And ICON Join Forces To Bring New Productivity To Capturing Patient Voice In Clinical Trials

Medidata And ICON Join Forces To Bring New Productivity To Capturing Patient Voice In Clinical Trials

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, and ICON plc, (NASDAQ:ICLR) a global provider of outsourced development services to the...

This can make a technology stock attractive to investors

This can make a technology stock attractive to investors

Companies that beat and raise earnings guidance can be attractive stock investments.

ICON: Pfizer And Roche Join ADDPLAN DF Consortium

ICON: Pfizer And Roche Join ADDPLAN DF Consortium

ICON plc (NASDAQ: ICLR), today announced that Pfizer and Roche have joined the ADDPLAN ® DF Consortium.

ICON Shareholders Vote In Favour Of All Resolutions At Its Annual General Meeting

ICON Shareholders Vote In Favour Of All Resolutions At Its Annual General Meeting

ICON plc , (NASDAQ:ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that all resolutions at the Annual General...

ICON Reports Second Quarter 2014 And Increases Earnings Guidance

ICON Reports Second Quarter 2014 And Increases Earnings Guidance

ICON plc , (NASDAQ:ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the second quarter...

First Week of August 16th Options Trading For Icon (ICLR)

First Week of August 16th Options Trading For Icon (ICLR)

Investors in Icon plc saw new options begin trading this week, for the August 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ICLR options chain for the new August 16th contracts and identified one put and one call contract of particular interest.

First Week of January 2015 Options Trading For Icon (ICLR)

First Week of January 2015 Options Trading For Icon (ICLR)

Investors in Icon plc saw new options begin trading this week, for the January 2015 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 242 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Sellers in May: What a surprise!

Sellers in May: What a surprise!

Why the market slump isn't a bear market.

ICON To Webcast Analyst Day Meeting

ICON To Webcast Analyst Day Meeting

ICON plc, (NASDAQ:ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it will provide a live webcast of its...

ICON Completes Acquisition Of Aptiv Solutions

ICON Completes Acquisition Of Aptiv Solutions

ICON plc, (NASDAQ: ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has completed the previously announced...

ICON Announces Appointment Of Dr. Hugh Brady To Board Of Directors

ICON Announces Appointment Of Dr. Hugh Brady To Board Of Directors

ICON plc, (NASDAQ: ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the appointment of Dr.

ICON Reports First Quarter 2014

ICON Reports First Quarter 2014

ICON plc, (NASDAQ:ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the first quarter...

Aptiv Solutions To Be Acquired By ICON

Aptiv Solutions To Be Acquired By ICON

Aptiv Solutions, a global biopharmaceutical and medical device development services company leading the design and implementation of innovative approaches that improve data quality, efficiency, and productivity of...

ICON To Acquire Aptiv Solutions

ICON To Acquire Aptiv Solutions

ICON plc , (NASDAQ:ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has agreed, subject to certain closing...

Interesting ICLR Put And Call Options For October 18th

Interesting ICLR Put And Call Options For October 18th

Investors in Icon plc saw new options begin trading this week, for the October 18th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 234 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

ICON Reports Fourth Quarter 2013 Revenue Of $345 Million, Up 15% Year On Year And EPS Of 53c, Up 56% Year On Year. Full Year 2013 Revenue Was $1.34 Billion, Up 20% Year On Year, EPS Was $1.77 Up 77% Year On Year. Guidance Issued For 2014.

ICON Reports Fourth Quarter 2013 Revenue Of $345 Million, Up 15% Year On Year And EPS Of 53c, Up 56% Year On Year. Full Year 2013 Revenue Was $1.34 Billion, Up 20% Year On Year, EPS Was $1.77 Up 77% Year On Year. Guidance Issued For 2014.

ICON plc, (NASDAQ:ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the full year and...

ICON Announces Appointment Of Ms. Mary Pendergast To Board Of Directors

ICON Announces Appointment Of Ms. Mary Pendergast To Board Of Directors

ICON plc, (NASDAQ: ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the appointment of Ms.

2 Stocks Rising on Unusual Volume

2 Stocks Rising on Unusual Volume

Unusual volume can signal that hedge funds and momentum traders are piling into a stock ahead of a catalyst.

ICON Appoints Dr. Steve Cutler As Chief Operating Officer

ICON Appoints Dr. Steve Cutler As Chief Operating Officer

ICON plc, (NASDAQ: ICLR) a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that Dr.

4 Stocks Rising on Unusual Volume

4 Stocks Rising on Unusual Volume

Often when above-average volume moves into an equity, it precedes a large spike in volatility.

Interesting ICLR Put And Call Options For July 2014

Interesting ICLR Put And Call Options For July 2014

Investors in Icon plc saw new options begin trading this week, for the July 2014 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 235 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

ICON Reports Third Quarter 2013 Revenue Of $340 Million, Up 19% Year On Year, EPS Of 45C And Raises FY 2013 Guidance.

ICON Reports Third Quarter 2013 Revenue Of $340 Million, Up 19% Year On Year, EPS Of 45C And Raises FY 2013 Guidance.

ICON plc, (NASDAQ: ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the third quarter...

ICON Launches New Patient Safety Service For Real-time Analysis Of Aggregated Safety Data

ICON Launches New Patient Safety Service For Real-time Analysis Of Aggregated Safety Data

ICON plc, (NASDAQ: ICLR) a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today launched ICONIK Patient Safety, the latest service to leverage...

TheStreet Quant Rating: A (Buy)